We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Aspiring to Awesome- Patient Preference Privacy Selections in EMR

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01862133
Recruitment Status : Completed
First Posted : May 24, 2013
Results First Posted : March 23, 2015
Last Update Posted : January 19, 2018
Sponsor:
Collaborators:
Information provided by (Responsible Party):

Study Type: Observational
Study Design: Observational Model: Cohort;   Time Perspective: Prospective
Condition: Sexually Transmitted Diseases
Intervention: Other: Patient preferences

  Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
107 primary care clinic patients were enrolled and signed informed consent statements. 2 failed to complete the patient preference dialog and study questionnaire.

Reporting Groups
  Description
Patient Preferences

Patients were eligible if they had visited their primary care physician at least twice in the previous 1 year and were fluent in English. Each patient subject used an online program to record their preferences what each of their providers can see. The electronic medical record (EMR) will then apply them to data displays.

141 adult primary care clinic patients were approached 38 refused to participate 107 were enrolled and signed informed consent statements 2 failed to complete the patient preference dialog and study questionnaire 105 completed the patient preference dialog and were included in the study 92 subjects returned to the clinic during the 6-month study

Primary Care Providers

All healthcare providers (physicians, nurses, and other clinic staff) were eligible to participate in this study. For those enrolled, display of patient data in the EMR was dictated by the patient subject's preferences for who should see what data.

Patient preferences: Software for recording patients' preferences for which providers see which parts of their EMRs, and EMR software for restricting access to data based on patients' preferences.

  • 11 physicians and 23 additional clinic staff (5 nurses, 4 clinical nurse assistants, 3 physicians' assistants, 2 nurse practitioners, and 9 medical assistance worked in the study primary care clinic at the time of the study
  • 2 physicians were excluded because their patients were mainly Spanish speaking
  • 1 physician verbally agreed to be in the study but never signed the informed consent statement
  • 8 physicians and all 23 of the other clinic staff were enrolled and signed informed consent statements and completed in the study

Participant Flow:   Overall Study
    Patient Preferences   Primary Care Providers
STARTED   105   31 
Returned During 6 mo Study   92   31 
COMPLETED   105 [1]   31 
NOT COMPLETED   0   0 
[1] All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study



  Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
Data collected from enrolled patients was limited to gender, race/ethnicity, age, and whether they had highly sensitive information (as defined in Methods) in their electronic health records. This information was obtained from patients' electronic medical records only.

Reporting Groups
  Description
Patient Preferences Patients were eligible if they had visited their primary care physician at least twice in the previous 1 year and were fluent in English. Each patient subject used an online program to record their preferences what each of their providers can see. The electronic medical record (EMR) will then apply them to data displays.

Baseline Measures
   Patient Preferences 
Overall Participants Analyzed 
[Units: Participants]
 105 
Age 
[Units: Years]
Mean (Standard Deviation)
 55  (13) 
Sex: Female, Male 
[Units: Participants]
Count of Participants
 
Female      73  69.5% 
Male      32  30.5% 
Region of Enrollment 
[Units: Participants]
 
United States   105 


  Outcome Measures

1.  Primary:   Number of Patients Recording Preferences to Restrict Provider Access to Some or All Electronic Health Record (EHR) Data   [ Time Frame: 6 month study ]

2.  Primary:   Providers' Opinion of Patients' Controlling EHR Access   [ Time Frame: 6 month study ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
We could not separate the anonymous post-study provider survey results and comments by provider type because the numbers within the physicians and nurses were sufficiently small that anonymity could have been lost.


  More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.


Results Point of Contact:  
Name/Title: William M. Tierney, MD
Organization: Regenstrief Institute
phone: (317) 274-9094
e-mail: wtierney@regenstrief.org


Publications of Results:
Other Publications:

Responsible Party: Indiana University
ClinicalTrials.gov Identifier: NCT01862133     History of Changes
Other Study ID Numbers: CFDA# 93.719
First Submitted: May 15, 2013
First Posted: May 24, 2013
Results First Submitted: March 12, 2015
Results First Posted: March 23, 2015
Last Update Posted: January 19, 2018